- Home
- VAL vs ICLR Comparison
VAL vs ICLR Comparison
Compare VAL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VAL | ICLR |
|---|---|---|
| Founded | 1975 | 1990 |
| Country | Bermuda | Ireland |
| Employees | 5642 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 7.1B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | VAL | ICLR |
|---|---|---|
| Price | $97.48 | $99.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $63.50 | ★ $182.08 |
| AVG Volume (30 Days) | 1.2M | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.62 | N/A |
| P/E Ratio | $16.22 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.15 | $66.57 |
| 52 Week High | $102.20 | $211.00 |
Technical Indicators
Market Signals| Indicator | VAL | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 63.98 | 36.51 |
| Support Level | $45.71 | $66.57 |
| Resistance Level | $102.20 | $113.88 |
| Average True Range (ATR) | 4.00 | 4.79 |
| MACD | -1.02 | 1.83 |
| Stochastic Oscillator | 88.96 | 27.85 |
Price Performance
Historical ComparisonAbout VAL Valaris Limited
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.